I understand the frustration that many of you are feeling regarding IMNX, but repeat that in the big scheme of things this is not a big deal. If you bought in the mid 60s, and had good reasons for doing so, and if there has been no change in fundamentals, which there hasn't, then if the stock goes to 50, or 40, isn't it a better buy? I do agree though, that there will be no more news capable of moving the stock until the FDA filing early next year (and perhaps the next earnings report). So if you trade on news, this is not the place to be right now. But if you are an investor looking for good long term bets, the price decline in IMNX definetly has a silver lining.
|
